Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 43% · prior close shown (market closed)
PETMED EXPRESS INC shows decelerating business momentum based on AlphaOS pipeline evidence.
Why it matters: Revenue -20% YoY in Q2 FY2026.
3 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 0d ago
PETS's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on PETS.
Free accounts see more of this; Premium sees all of it.
Reported figures for PETMED EXPRESS INC — research only, not investment advice.
Updated
What happened recently for PETMED EXPRESS INC (PETS) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
PETS's AI investment thesis
Upgrade to Premium for PETS's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$1.56
Market cap
$33.71M
Profitable
No
Revenue $179.02M
Net income
$-57.29M
FY Mar 31, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
US equity research on AlphaOS
Investment Snapshot above is the primary AlphaOS analysis for PETMED EXPRESS INC — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow PETMED EXPRESS INC through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.